NCT07151859View on ClinicalTrials.gov

Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Aesthetic Improvement of the SkinSkin Hydration in Healthy VolunteersSkin ElasticitySkin TurgorSubject Satisfaction

Interventions

DEVICE

PN30 (RDM16)

PN30 is a viscoelastic, sterile gel, in a disposable prefilled syringe for intradermal infiltration.PN30 contains polynucleotides (3%). The polynucleotides contained in the device are substances of natural, fish-derived origin, highly purified.

All Listed Sponsors

collaborator

1Med

OTHER

lead

Mastelli S.r.l

INDUSTRY

NCT07151859 - Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration | Biotech Hunter | Biotech Hunter